A randomized trial shows no significant difference in the primary endpoint of quality of life at 6 months between treatment with digoxin vs the beta-blocker bisoprolol (Zebeta) in patients with atrial ...

A Spanish study found that the mortality rates of patients with digoxin poisoning in emergency departments (EDs) were 4.5% at 7 days and 11.1% at 30 days and that cardiovascular and neurologic ...

We had an older female with chronic kidney disease who started complaining about seeing yellow lights and being short of breath. She had a history of heart failure and was treated with digoxin. When ...

THE ascendancy of digitalis intoxication in recent years has made this problem and its recognition an ever important clinical consideration in every patient receiving the drug. Much of this increase ...

Evaluation of the drug by Canadian regulatory authorities is under way. Paladin Labs will take over distribution of BTG’s treatment for digoxin toxicity or overdose in Canada. DigiFab™ is currently ...

THE heightened sensitivity of the diseased myocardium to digitalis, as manifested by toxic responses to average or small doses, is well established. 1 Chelating compounds that act by removing calcium ...

Explaination: As previously stated, digoxin toxicity itself results in hyperkalemia, however hypokalemia significantly increases the risk for serious arrhythmias in the digoxin toxic patient. Digoxin ...

Digoxin toxicity is worsened in states of hypokalemia (low potassium) since digoxin normally binds to the ATPase pump on the same site as potassium. When potassium levels are low, digoxin can more ...

In patients with heart failure with reduced ejection fraction (HFrEF) who have an implantable cardioverter-defibrillator (ICD), the use of digoxin may increase the risk of ventricular tachyarrhythmia ...

Digoxin, a cardiac glycoside derived from the foxglove plant, has been a mainstay of treatment in systolic heart failure and in rate control for atrial fibrillation. By inhibiting the cardiac ...

Patients with rheumatic heart disease who took the heart failure drug digoxin were 18% less likely to die or experience new-onset or worsening heart failure during a two-year follow-up compared with ...

University at Buffalo researchers have identified for the first time an enzyme in the foxglove plant that is responsible for the production of compounds needed to make the heart failure drug digoxin.